
Low dose assessment of the carcinogenicity of furan in male F344/N Nctr rats in a 2-year gavage study
Keywords: Furan; Tumorigenicity; Cholangiocarcinoma; Cholangiofibrosis; Rats; Bioassay; BMD; benchmark dose; BMDL; lower limit of benchmark dose; BW; body weight; FDA; Food and Drug Administration; GLP; Good Laboratory Practice; MOE; margin of exposure; NCTR; Natio